Annual CFO
-$59.24 M
-$24.67 M-71.34%
December 31, 2023
Summary
- As of February 12, 2025, SCPH annual cash flow from operations is -$59.24 million, with the most recent change of -$24.67 million (-71.34%) on December 31, 2023.
- During the last 3 years, SCPH annual CFO has fallen by -$31.55 million (-113.93%).
- SCPH annual CFO is now -514.56% below its all-time high of -$9.64 million, reached on December 31, 2015.
Performance
SCPH Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFO
-$17.42 M
+$2.80 M+13.86%
September 30, 2024
Summary
- As of February 12, 2025, SCPH quarterly cash flow from operations is -$17.42 million, with the most recent change of +$2.80 million (+13.86%) on September 30, 2024.
- Over the past year, SCPH quarterly CFO has dropped by -$2.27 million (-14.95%).
- SCPH quarterly CFO is now -345.51% below its all-time high of -$3.91 million, reached on June 30, 2019.
Performance
SCPH Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFO
-$70.51 M
-$3.97 M-5.97%
September 30, 2024
Summary
- As of February 12, 2025, SCPH TTM cash flow from operations is -$70.51 million, with the most recent change of -$3.97 million (-5.97%) on September 30, 2024.
- Over the past year, SCPH TTM CFO has dropped by -$11.27 million (-19.02%).
- SCPH TTM CFO is now -1386.61% below its all-time high of -$4.74 million, reached on March 31, 2017.
Performance
SCPH TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
SCPH Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -71.3% | -14.9% | -19.0% |
| 3 y3 years | -113.9% | -47.2% | -103.9% |
| 5 y5 years | -105.6% | -47.2% | -103.9% |
SCPH Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -118.2% | at low | -145.5% | +13.9% | -172.2% | at low |
| 5 y | 5-year | -118.2% | at low | -262.4% | +13.9% | -172.2% | at low |
| alltime | all time | -514.6% | at low | -345.5% | +13.9% | -1386.6% | at low |
ScPharmaceuticals Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$17.42 M(-13.9%) | -$70.51 M(+6.0%) |
| Jun 2024 | - | -$20.23 M(+14.3%) | -$66.54 M(+10.1%) |
| Mar 2024 | - | -$17.70 M(+16.8%) | -$60.45 M(+2.0%) |
| Dec 2023 | -$59.24 M(+71.3%) | -$15.16 M(+12.7%) | -$59.24 M(+5.9%) |
| Sep 2023 | - | -$13.45 M(-4.9%) | -$55.92 M(+10.4%) |
| Jun 2023 | - | -$14.14 M(-14.3%) | -$50.67 M(+15.9%) |
| Mar 2023 | - | -$16.49 M(+39.3%) | -$43.70 M(+26.4%) |
| Dec 2022 | -$34.58 M(+27.4%) | -$11.84 M(+44.4%) | -$34.58 M(+15.9%) |
| Sep 2022 | - | -$8.20 M(+14.2%) | -$29.84 M(+11.3%) |
| Jun 2022 | - | -$7.17 M(-2.6%) | -$26.81 M(+3.5%) |
| Mar 2022 | - | -$7.37 M(+3.8%) | -$25.91 M(-4.6%) |
| Dec 2021 | -$27.15 M(-2.0%) | -$7.10 M(+37.4%) | -$27.15 M(-7.1%) |
| Sep 2021 | - | -$5.17 M(-17.6%) | -$29.23 M(+1.2%) |
| Jun 2021 | - | -$6.27 M(-27.2%) | -$28.87 M(+1.1%) |
| Mar 2021 | - | -$8.62 M(-6.2%) | -$28.57 M(+3.1%) |
| Dec 2020 | -$27.69 M | -$9.18 M(+90.9%) | -$27.69 M(-17.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2020 | - | -$4.81 M(-19.4%) | -$33.35 M(-2.3%) |
| Jun 2020 | - | -$5.96 M(-23.0%) | -$34.12 M(+6.4%) |
| Mar 2020 | - | -$7.74 M(-47.8%) | -$32.07 M(+5.3%) |
| Dec 2019 | -$30.44 M(+5.7%) | -$14.84 M(+166.0%) | -$30.44 M(+42.2%) |
| Sep 2019 | - | -$5.58 M(+42.6%) | -$21.41 M(+0.5%) |
| Jun 2019 | - | -$3.91 M(-36.1%) | -$21.30 M(-17.6%) |
| Mar 2019 | - | -$6.12 M(+5.5%) | -$25.86 M(-10.3%) |
| Dec 2018 | -$28.81 M(+27.0%) | -$5.80 M(+6.1%) | -$28.81 M(-0.5%) |
| Sep 2018 | - | -$5.46 M(-35.5%) | -$28.95 M(-1.4%) |
| Jun 2018 | - | -$8.47 M(-6.6%) | -$29.37 M(+8.7%) |
| Mar 2018 | - | -$9.07 M(+52.7%) | -$27.01 M(+19.1%) |
| Dec 2017 | -$22.68 M(+46.8%) | -$5.94 M(+1.0%) | -$22.68 M(+35.5%) |
| Sep 2017 | - | -$5.88 M(-3.8%) | -$16.74 M(+54.2%) |
| Jun 2017 | - | -$6.11 M(+28.9%) | -$10.86 M(+128.9%) |
| Mar 2017 | - | -$4.74 M | -$4.74 M |
| Dec 2016 | -$15.46 M(+60.3%) | - | - |
| Dec 2015 | -$9.64 M | - | - |
FAQ
- What is scPharmaceuticals annual cash flow from operations?
- What is the all time high annual CFO for scPharmaceuticals?
- What is scPharmaceuticals annual CFO year-on-year change?
- What is scPharmaceuticals quarterly cash flow from operations?
- What is the all time high quarterly CFO for scPharmaceuticals?
- What is scPharmaceuticals quarterly CFO year-on-year change?
- What is scPharmaceuticals TTM cash flow from operations?
- What is the all time high TTM CFO for scPharmaceuticals?
- What is scPharmaceuticals TTM CFO year-on-year change?
What is scPharmaceuticals annual cash flow from operations?
The current annual CFO of SCPH is -$59.24 M
What is the all time high annual CFO for scPharmaceuticals?
scPharmaceuticals all-time high annual cash flow from operations is -$9.64 M
What is scPharmaceuticals annual CFO year-on-year change?
Over the past year, SCPH annual cash flow from operations has changed by -$24.67 M (-71.34%)
What is scPharmaceuticals quarterly cash flow from operations?
The current quarterly CFO of SCPH is -$17.42 M
What is the all time high quarterly CFO for scPharmaceuticals?
scPharmaceuticals all-time high quarterly cash flow from operations is -$3.91 M
What is scPharmaceuticals quarterly CFO year-on-year change?
Over the past year, SCPH quarterly cash flow from operations has changed by -$2.27 M (-14.95%)
What is scPharmaceuticals TTM cash flow from operations?
The current TTM CFO of SCPH is -$70.51 M
What is the all time high TTM CFO for scPharmaceuticals?
scPharmaceuticals all-time high TTM cash flow from operations is -$4.74 M
What is scPharmaceuticals TTM CFO year-on-year change?
Over the past year, SCPH TTM cash flow from operations has changed by -$11.27 M (-19.02%)